Summary of Use during Lactation

There is no published experience with ubrogepant during breastfeeding. Ubrogepant is 87% protein bound, so levels in milk are likely low. If ubrogepant is required by the mother of an older infant, it is not a reason to discontinue breastfeeding, but until more data become available, an alternate drug may be preferred, especially while nursing a newborn or preterm infant.

Drug Levels

Maternal Levels. Relevant published information was not found as of the revision date.

Infant Levels. Relevant published information was not found as of the revision date.

Effects in Breastfed Infants

Relevant published information was not found as of the revision date.

Effects on Lactation and Breastmilk

Relevant published information was not found as of the revision date.

Alternate Drugs to Consider

Eletriptan, Rizatriptan, Sumatriptan, Zolmitriptan

Substance Name

Ubrogepant

CAS Registry Number

1374248-77-7

Drug Class

Breast Feeding

Lactation

Analgesics

Calcitonin Gene Related Peptide Receptor Antagonists

CGRP-R Inhibitors